12 Health Care Stocks Moving In Wednesday’s After-Market Session
Gainers
TransCode Therapeutics (NASDAQ:RNAZ) shares increased by 5.4% to $2.73 during Wednesday's after-market session. The company's market cap stands at $35.2 million.
Mid-Afternoon Market Update: US Stocks Turn Positive; Hovnanian Enterprises Shares Slide
Toward the end of trading Wednesday, the Dow traded up 0.08% to 34,342.65 while the NASDAQ rose 0.38% to 14,489.14. The S&P also rose, gaining 0.19% to 4,353.99.
Mid-Day Market Update: Dow Tumbles Over 300 Points; Acer Therapeutics Shares Jump
Midway through trading Wednesday, the Dow traded down 0.92% to 33,997.95 while the NASDAQ fell 0.49% to 14,362.47. The S&P also fell, dropping 0.75% to 4,313.33.
26 Stocks Moving In Wednesday’s Mid-Day Session
Gainers
Voyager Therapeutics, Inc. (NASDAQ: VYGR) shares jumped 54.1% to $3.8050 after the company announced licensing option agreement with Pfizer for capsids generated from Voyager's RNA-driven TRACER screening technology.
Mid-Morning Market Update: Markets Open Lower; Acuity Brands Posts Upbeat Q4 Results
Following the market opening Wednesday, the Dow traded down 1.12% to 33,929.34 while the NASDAQ fell 0.69% to 14,334.78. The S&P also fell, dropping 0.90% to 4,306.41.
Voyager Therapeutics Stock Soars On License Option Pact With Pfizer
Voyager Therapeutics Inc (NASDAQ:VYGR) has announced licensing option agreement with Pfizer Inc (NYSE:PFE) for capsids generated from Voyager’s RNA-driven TRACER screening technology. Related: Voyager…
The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer’s Sleep Disorder Drug Filing Accepted For Review, Voyager’s Licensing Options Deal
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Oct. 5)